The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma.
about
Exploiting Literature-derived Knowledge and Semantics to Identify Potential Prostate Cancer DrugsMortality results from a randomized prostate-cancer screening trialThe quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397).A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer.Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and ProgressionNovel diagnostic biomarkers for prostate cancer.Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art.Management of complications of androgen deprivation therapy in the older man.Risk stratification in the hormonal treatment of patients with prostate cancerThe natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomy.Metabolic complications and increased cardiovascular risks as a result of androgen deprivation therapy in men with prostate cancer.The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study.Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer.Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.Predictors of adherence to a 12-week exercise program among men treated for prostate cancer: ENGAGE study.Adverse effects of androgen deprivation therapy in prostate cancer: Current management issues.Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy.Factors associated with adherence to physical activity guidelines in patients with prostate cancer.Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy.Androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use?Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry.The health and well-being of prostate cancer patients and male-to-female transsexuals on androgen deprivation therapy: a qualitative study with comments on expectations and estrogen.Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 years.Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
P2860
Q22122725-18DF9D64-3FA6-4EA0-A28E-EE651E2F8663Q24601536-70F5A2D0-E1AA-4BF9-8BF8-BD25898A658CQ31083661-9BC497FD-AF38-4DDB-9A89-DDEC11FE703FQ33462970-3E9A1089-9500-42B6-8891-770242ADC953Q34090617-1194DF87-C5DF-47DE-8675-05CB79F04215Q34231678-3EBA4E5D-622F-412B-813A-3FE40BE34C2BQ34417815-9737405A-47CF-4AA7-AA03-51840850B016Q34782101-5ACC4582-6577-4B57-A7A7-15FEF2FD5AFEQ35076189-30024716-1848-4373-94EF-058260EAD4D2Q35125242-97B80D6A-4CC8-4540-AFBA-25BCCD360280Q35433102-0D49F8D6-AEDF-44DA-B130-B0C825A3F39CQ36238011-16BC8ACB-CC2E-4F1A-8D79-E69586BC7C9CQ36814324-2CAFF54E-B9AF-48BC-9E7A-321F040389D1Q36841565-9F98A12F-AA30-42D1-84E0-E84882CBCB3AQ36895043-95E828A8-9BC6-4B0D-82F1-10F46BC3BC1CQ37260338-11D13104-21B1-4B39-B963-FFACCDBC3FEDQ38587219-4C82AAC5-72BE-44EB-BBC2-06EDFF4C1285Q43796722-5810049B-3FFF-4464-A006-19D475E4D9ADQ43818532-40B5FF92-9D3B-4109-A214-392774A003CEQ44593887-4195E01D-50BF-4FDE-8695-7576FBD92A07Q45158362-D6C2C601-E9C7-4BF7-8AA6-25B7F0D53720Q46159736-45A7B684-06F9-41FC-9BBD-2B40B1FCCEC3Q46619020-29A2A55D-CD7E-4384-9524-4D3355923C69Q48322804-9A18064C-FED7-4636-8AD1-FF89ACAB9AE9Q52926585-40E67FFD-9ECA-4801-A4FF-3559C3F16057Q52967287-919C13E0-7A44-4DE2-8861-184DFACC0530
P2860
The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The impact of androgen depriva ...... ectomy for prostate carcinoma.
@ast
The impact of androgen depriva ...... ectomy for prostate carcinoma.
@en
The impact of androgen depriva ...... ectomy for prostate carcinoma.
@nl
type
label
The impact of androgen depriva ...... ectomy for prostate carcinoma.
@ast
The impact of androgen depriva ...... ectomy for prostate carcinoma.
@en
The impact of androgen depriva ...... ectomy for prostate carcinoma.
@nl
prefLabel
The impact of androgen depriva ...... ectomy for prostate carcinoma.
@ast
The impact of androgen depriva ...... ectomy for prostate carcinoma.
@en
The impact of androgen depriva ...... ectomy for prostate carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
The impact of androgen depriva ...... ectomy for prostate carcinoma.
@en
P2093
Diana B Elliott
Elizabeth Walker Corkery
Floyd J Fowler
Mary McNaughton Collins
Michael J Barry
P2860
P304
P356
10.1002/CNCR.10656
P407
P577
2002-07-01T00:00:00Z